Keyphrases
Epidermolysis Bullosa
100%
Graft-versus-host Disease (GvHD)
73%
Gene Editing
60%
Cas9 Protein
60%
T Cells
59%
Induced Pluripotent Stem Cells (iPSCs)
52%
Fanconi Anemia
50%
α-L-iduronidase
47%
TALEN
45%
Treg
38%
Clustered Regularly Interspaced Short Palindromic repeats/Cas9
38%
Gene Expression
37%
Base Editor
35%
Photosystem II
35%
Multiplex
35%
High Efficiency
33%
Regulatory T Cells
32%
Cellular Engineering
30%
Hematopoietic Stem Cells
28%
Mouse Model
28%
Gene Therapy
27%
Chimeric Antigen Receptor T Cells (CAR-T)
27%
Lethality
27%
COVID-19
26%
T Cell Receptor
25%
Prime Editing
25%
Double-strand Breaks
23%
CD19
23%
Stem Cells
22%
Type VII Collagen
22%
Adenine Base Editor
22%
Genetic Engineering
22%
Nuclease
21%
Escherichia Coli
21%
Bone Marrow Transplantation
21%
Primary T Cells
21%
MPS IH
21%
Minicircle DNA
20%
Human Cells
20%
Angiotensin-converting Enzyme 2 (ACE2)
20%
T Cell Engineering
20%
Negatively Regulate
20%
Soluble Expression
20%
Bioactive
20%
Gene Correction
20%
Off-target Effects
20%
DNA Sequencing
18%
Donor T Cell
18%
Patient-specific
17%
Gene Targeting
17%
Biochemistry, Genetics and Molecular Biology
Genome Editing
75%
Cas9
73%
Epidermolysis bullosa
70%
Nuclease
54%
Induced Pluripotent Stem Cell
53%
CRISPR
49%
CRISPR/Cas9
47%
T Cell
46%
Hematopoietic Cell
45%
Cell Engineering
41%
Iduronidase
40%
Hurler Syndrome
37%
Fibroblast
31%
Stem Cell
31%
Gene Therapy
26%
Transcription Activator-Like Effector Nuclease
24%
Genetic Disorder
22%
Adenine
21%
Copurification
20%
Minicircle
20%
Plasmid
18%
SARS Coronavirus
16%
Gene Product
16%
Mediator
16%
Genetics
16%
Revertant
16%
Genomics
15%
Wild Type
15%
T Cell Receptor
15%
RNA
14%
Gene Expression
14%
Mammalian Cell
13%
Zinc Finger Nuclease
13%
Progenitor Cell
13%
Cytosine
12%
Bacteriophage
12%
Mouse Model
12%
Prevalence
12%
Gene Targeting
12%
Maltose-Binding Protein
12%
Mosaicism
12%
Cell Transplantation
12%
Transgenics
11%
CD34
11%
Enzyme
11%
Host
11%
Escherichia coli
11%
Recombinant Protein
11%
Gene Mutation
10%
Immunity
10%
Medicine and Dentistry
Epidermolysis Bullosa Dystrophica
70%
T Cell
67%
Base
58%
Induced Pluripotent Stem Cell
52%
Cas9
43%
Hematopoietic Cell
43%
Disease
32%
Hurler Syndrome
30%
Epidermolysis bullosa
30%
Fanconi Anemia
30%
Chimeric Antigen Receptor T-Cell
27%
Levo Iduronidase
27%
Stem Cell
27%
Gene Therapy
25%
Graft Versus Host Reaction
22%
Clustered Regularly Interspaced Short Palindromic Repeat
22%
Mesenchymal Stem Cell
21%
Acute Graft Versus Host Disease
20%
Bone Marrow Transplantation
20%
Angiotensin Converting Enzyme 2
20%
Nuclease
19%
Adenine
18%
Collagen Type 7
18%
Fibroblast
17%
Revertant
16%
B Cell
15%
Medicine
15%
Progenitor Cell
15%
In Vitro
14%
Transgenic Mouse
14%
Lethality
13%
Genome Engineering
13%
Immunosuppressive Drug
13%
Gene Targeting
13%
Cytosine
12%
Cancer
12%
Mosaicism
12%
Cell Transplantation
12%
Protein P53
12%
Graft Versus Leukemia Effect
11%
Recombinant Protein
11%
Transposon
11%
Chimeric Antigen Receptor
10%
Lysosomal Storage Disease
10%
Minicircle DNA
10%
Cell Therapy
10%
DNA Mismatch Repair
10%
Retinoid X Receptor
10%
Keratinocyte Growth Factor
10%
Human Immunodeficiency Virus 1
10%
